Evidence map›Paper›PMID 41796275›Full record

ArticleIntensive care medicine experimental2026

Admission systemic immune-inflammatory index predicts long-term mortality in patients with acute ischemic stroke: a retrospective analysis of the MIMIC-III database.

Xiao Su, Xiuqing Tong, Ning Li, Boran Wang, Wei Gao, Yanmo Wang

Abstract read
In one paragraph

Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiao SuDepartment of Neurology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China. Suxiao03140615@163.com.ORCID http://orcid.org/0000-0003-1397-4720
Xiuqing Tong *Department of Neurology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
Ning Li *Department of International Medicine, Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia, China.
Boran Wang *Department of Ultrasound Medicine, Inner Mongolia Medical College Affiliated Hospital, Hohhot, Inner Mongolia, China.
Wei Gao *Department of Medical Imaging, Inner Mongolia Medical College Affiliated Hospital, Hohhot, Inner Mongolia, China.
Yanmo Wang *Department of nuclear medicine, Inner Mongolia Medical University Cancer Hospital, Hohhot, Inner Mongolia, China.

Funding

Inner Mongolia Autonomous Region Health and Wellness Commission 2023 High-level Clinical Specialty Construction Science and Technology Project for Public Hospitals in the Capital Region 2023SGGZ0703Inner Mongolia Medical University Youth Training Programme YKD2021QN017Science and Technology Program of the Joint Fund for Scientific Research of Public Hospitals of the Inner Mongolia Academy of Medical Sciences 2025GLLH0107the Inner Mongolia Natural Science Foundation 2026SHZR0128
6 · The paper itself

Abstract

backgroundThe Aggregate Index of Systemic Inflammation (AISI) is a novel index based on platelets, neutrophils, and lymphocytes associated with the prognosis of patients with cancer and infectious diseases. However, its application in acute ischemic stroke (AIS) has rarely been reported. This study evaluated stroke prognosis using AISI by examining the relationship between levels of systemic immunoinflammatory indices at admission and patient outcomes at different times after onset.

methodsThis was a retrospective cohort study. The data from 1222 stroke patients were obtained from multiparameter intelligent monitoring in the Intensive Care III database (MIMIC-III). Cox proportional risk model was conducted to estimate the relation between AISI, all-cause mortality, and ischemic. The findings were further validated with restricted cubic spline (RCS) and subgroup analyses.

resultsA total of 1222 patients with AIS were classified into tertiles based on AISI levels, tertile 1: low AISI, AISI levels less than 3881 (n = 408), tertile 2: medium AISI, AISI levels 3881 to 8354 (n = 408), and tertile 3: high AISI, AISI levels greater than 8354 (n = 407). After adjusting for multiple covariates, it was found that AISI was related to all-cause mortality in stroke patients. Patients with high AISI had a 31% increased risk of death after 90 days (HR = 1.31, 95% CI 1.03-1.67, P = 0.03) compared to patients with low AISI. Patients with high AISI had a 27% increased risk of death after 365 days (HR = 1.27, 95% CI 1.03-1.58, P = 0.029) than low AISI patients. Furthermore, compared with patients with low AISI, patients with high AISI had a 30% increased risk of death after two years (HR = 1.30, 95% CI 1.05-1.60, P = 0.014). During the 2-year follow-up period, the use of RCS showed that the mortality rate gradually increased with the increase of AISI value after 5841.5.

conclusionSystemic immunoinflammatory indices are related to long-term adverse outcomes in patients with AIS. Therefore, AISI is a promising inflammatory index for predicting the long-term prognosis of stroke.

Indexed as

Acute ischemic strokeAISIBiomarkerIntensive care unitsMIMIC-IIIMortality

Identifiers

PMID41796275
PMCPMC12968109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.